产品名称 | NebuSelect™ Recombinant Human SEMA4B, His-tag |
---|---|
目录号 | NBL-242130 |
别名 | SEMA4B; Semaphorin-4B; Semaphorin-C; SEMA4B; KIAA1745; SEMAC; MGC131831; SemC |
外观 | see COA |
分子量 | Leu44-Glu717 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | Q9NPR2 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242130-100ug | 100ug | Inquire | Inquire | |
NBL-242130-1mg | 1mg | Inquire | Inquire | |
NBL-242130-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human SEMA4B, His-tag
Catalog#:
NBL-242130
Description:
NebuSelect™ Recombinant Human SEMA4B, His-tag(Cat#NBL-242130) is expressed in HEK293 with His tag at the C-Terminus.It contains Leu44-Glu717.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 75.8 kDa. Due to glycosylation, the protein migrates to 80-110 kDa based on Bis-Tris PAGE result.
Target Name:
SEMA4B; Semaphorin-4B; Semaphorin-C; SEMA4B; KIAA1745; SEMAC; MGC131831; SemC
Target Information:
Semaphorin 4B (SEMA4B) inhibits the invasion of non-small cell lung cancer (NSCLC) through PI3K-dependent suppression of MMP9 activation. SEMA4B may induce FoxO1 nuclear retention through suppressing PI3K/Akt signaling pathway, which subsequently inhibited cell growth through the direct nuclear target of FoxO1, p21. A role of SEMA4B in suppressing NSCLC growth, besides its role in inhibiting cell metastasis, and highlights SEMA4B as a promising therapeutic target for NSCLC.
Amino Acid Sequence:
Leu44-Glu717
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.